Company Filing History:
1 out of 832,880 Years Active: 2021-2024
Title: **Innovations by Alexey Repik: Pioneering Therapeutic Compositions**
Introduction
Alexey Repik, a prominent inventor located in Moscow, Russia, has made significant contributions to the field of biomedical innovation. With a focus on therapeutic compositions targeting human interleukin-1 beta (IL-1β), he holds two patents that reflect his expertise and commitment to advancing medical treatments.
Latest Patents
Repik's latest patents include the invention of an IL1-R1 derived inhibitor of IL-1β. This groundbreaking therapeutic composition is designed for both the treatment and prevention of diseases associated with the modulation of human IL-1β activity. The innovation is based on the engineering of a heterodimeric protein assembly capable of binding to human IL-1β and attenuating its function. This assembly consists of the extracellular portions of human IL1-R1 and human IL-1RAcP, or their functional fragments. Each portion is fused with distinct mutants of the Fc portion of human Ig Gamma-1, ensuring that the engineered assembly favors heteromeric dimer formation over homomeric assembly. This formulation is intended for administration in humans and animals.
Similarly, his other patent, titled "Human IL1-R1 derived inhibitor of IL-1β," also focuses on a therapeutic composition for the modulation of IL-1β activity. The innovation reiterates the effective binding of the heterodimeric protein assembly to human IL-1β, continuing to enhance therapeutic approaches in medical science.
Career Highlights
Throughout his career, Alexey Repik has remained dedicated to the intersection of biotechnology and therapeutic innovation. His work is pivotal in developing solutions for diseases associated with inflammatory responses, showcasing the impact of his inventions on the medical field.
Collaborations
Repik collaborates with esteemed colleagues, including Mikhail Samsonov and Vasily Ignatiev. Their combined expertise allows for interdisciplinary advancements in their research and contributions to biomedical sciences.
Conclusion
Alexey Repik is a notable inventor whose innovative work in therapeutic compositions for IL-1β modulation is shaping the future of medical treatments. His patented technologies demonstrate not only his inventive abilities but also the potential to significantly improve health outcomes for patients through targeted therapies.